U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022433

Expand all

BRILINTA (TICAGRELOR)
60MG
Marketing Status: Prescription
Active Ingredient: TICAGRELOR
Proprietary Name: BRILINTA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 60MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022433
Product Number: 002
Approval Date: Sep 3, 2015
Applicant Holder Full Name: ASTRAZENECA PHARMACEUTICALS LP
Marketing Status:  Prescription
Patent and Exclusivity Information
BRILINTA (TICAGRELOR)
90MG
Marketing Status: Prescription
Active Ingredient: TICAGRELOR
Proprietary Name: BRILINTA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 90MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N022433
Product Number: 001
Approval Date: Jul 20, 2011
Applicant Holder Full Name: ASTRAZENECA PHARMACEUTICALS LP
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top